GATC Health has developed a groundbreaking AI-based approach to mitigate and treat post-traumatic stress disorder (PTSD) through its Multiomics Advanced Technology (MAT) platform. The company's innovative method analyzes multiomic data, providing a holistic view of biological systems, to identify biomarkers for predicting PTSD risk and accelerate the generation of potential drug candidates. This approach has led to significant advancements in developing novel treatments for PTSD, with the potential to rapidly deliver transformative treatment options for veterans and civilians suffering from the condition. GATC Health's MAT platform is being used to develop safer and more effective treatments for PTSD, which affects millions globally, particularly among military veterans. The company has received a $5 million investment from the state of West Virginia to expand its AI-driven R&D hub in the state and accelerate its research on PTSD and opioid use disorder.
https://www.prnewswire.com/news-releases/transforming-ptsd-treatment-gatc-healths-ai-powered-multiomics-platform-unlocking-breakthroughs-in-drug-discovery-302347579.html